These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 13068032

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical trials with triethylene melamine].
    FERRARI M, KASDORF H.
    Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952
    [No Abstract] [Full Text] [Related]

  • 6. [Immediate results of triethylene melamine therapy of neoplastic diseases].
    LENTI G, GAVOSTO F.
    Minerva Med; 1953 Jan 06; 44(1-2):1-19. PubMed ID: 13054386
    [No Abstract] [Full Text] [Related]

  • 7. The clinical use of triethylene melamine.
    KRAVITZ SC, DIAMOND HD, CRAVER LF.
    Blood; 1952 Jul 06; 7(7):729-42. PubMed ID: 14934758
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Our experience with the application of triethylene melamine (TEM) in patients with malignant hemopathies].
    RUVIDIC R, NIKOLIC J.
    Med Glas; 1960 Sep 06; 14():435-42. PubMed ID: 13744964
    [No Abstract] [Full Text] [Related]

  • 10. TRIETHYLENE-MELAMINE.
    Br Med J; 1955 Jun 04; 1(4926):1380-1. PubMed ID: 14363905
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The therapeutic effect of triethylene melamine in hemoblastosis].
    SCHULZE E, FRANKE R, THIELE FH.
    Arztl Wochensch; 1953 Jul 17; 8(29):690-4. PubMed ID: 13080055
    [No Abstract] [Full Text] [Related]

  • 14. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].
    NEUMANN C.
    Klin Wochenschr; 1952 Dec 15; 30(47-48):1105-8. PubMed ID: 13023980
    [No Abstract] [Full Text] [Related]

  • 15. Triethylene melamine in the treatment of Hodgkin's disease and other lymphomas.
    ROTTINO A.
    N Y State J Med; 1952 Feb 01; 52(3):346-8. PubMed ID: 14899689
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Early resistance to triethylene melamine].
    LATTANZI A, PARDELLI G.
    Riforma Med; 1954 Jan 02; 68(1):7-12. PubMed ID: 13156339
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
    BERNARD J, MATHE G, WEIL M.
    Sang; 1957 Jan 02; 28(1):80-2. PubMed ID: 13432604
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.